Atosiban Acetate, Glycinamide, RWJ 22164, Atosibanum, Tractocile, Atosiban Acetate API, Atosiban Acetate Peptide, Peptide
GMP FDA COA
914453-95-5
Pharmaceutical Grade
99%
Chengdu
Chengdu Shengnuo, Shengnuo Biopharm
g
2025-11-15
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Product Description
-
Seller Information
-
History Price
-
DescriptionResearch & Reference Note
Atosiban Acetate, Glycinamide, RWJ 22164, Atosibanum, Tractocile, Atosiban Acetate API, Atosiban Acetate Peptide, Peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
CertificatesBasic Info-
Product Name:
Atosiban Acetate
CAS No.:914453-95-5
Molecular Formula:C45H71N11O14S2
InChIKeys:SVDWBHHCPXTODI-QIWYXCRTSA-N
Molecular Weight:1054.2 g/mol
Exact Mass:1053.462280
DSSTox ID:DTXSID60238569
Categories:
Characteristics-
PSA:
479.98000
XLogP3:3.04400
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Location:
Chengdu Shengnuo Biopharm Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
365
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2004
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product